Xcelience Debuts its Innovative and Interactive Forum XpertXchange„

Xcelience, LLC is expanding its expertise in the form of XpertXchange's8482;, a drug development forum whose goal is to explore and discuss current issues, best practices, innovations, perspectives, and technologies with drug development professionals. You can participate simply by logging on at www.drugdevforum.com.

This forum is a first for Xcelience and in the industry. XpertXchange's8482; will be moderated by the company'ss expert scientists who plan on backing up the company'ss mantra: Send us your biggest challenge, by discussing issues which range from preformulation to formulation to analytical and manufacturing topics.

The launching of Xcelience'ss Drug Development Forum creates a conduit for the exchange of ideas and concepts between the Pharmaceutical Industry and our Scientific Leaders, said Vice President of Xcelience, Randall Guthrie. The ability to share our problems, solutions, and concepts creates another first for Xcelience. To date no other service provider has moved forward in promoting the science and creating of an exchange mechanism such as this for formulation development.

Xcelience is the premier source for reliable drug discovery and innovative development solutions, providing an industry-experienced staff of scientists able to quickly and efficiently move compounds in research and development stages, to market. This Tampa-based formulation development laboratory has been around since 1997 and has built a reputation of providing customers with seamless, timely, consistent and superior service throughout the drug development process.

For more information, log on to www.xcelience.com.

Contact:
Mike Nabors
Teasdale Worldwide
(813) 868-1524




Xcelience Debuts its Innovative and Interactive Forum XpertXchange„



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***